Translational Research on Polygenic Risk Scores in Common Neurodegenerative Diseases - A Scoping Review Protocol
Acta Medica Academica · 2025
DOI: 10.5644/ama2006-124.463 ↗Kurz gefasst
Scoping Review in der Zeitschrift Acta Medica Academica, 2025. Verfasst von Mojca Čižek Sajko und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Institute for Genomic Medicine, University Medical Centre Ljubljana, Slovenia. mojca.cizek.sajko@kclj.si. Hauptthemen laut MEDLINE: Genetic Risk Score, Multifactorial Inheritance, Neurodegenerative Diseases, Translational Research, Biomedical. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
The purpose of this protocol is to clearly describe the process for the scoping review we plan to conduct on the topicof polygenic risk scores (PRS) in common neurodegenerative diseases. We will present the review's objective, the strategy forevidence search, the data extraction and analysis procedure, and how the results will be presented.
Methods
The inclusion criteria for the planned scoping review will focus on evidence sources that involve PRS applied to neurogenerative diseases such as Multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, and Amyotrophic lateral sclerosis in any phase of translational research, from early development to clinical implementation. This includes its use in risk prediction, early diagnosis, prognosis, and treatment decision-making. The research questions were created based on the population, context, and concept framework. We will consider both peer-reviewed papers and grey literature published in English or German for inclusion. Two independent reviewers will search for information.
Conclusion
The findings from the scoping review will be presented descriptively and summarized according to the research questions to illustrate the current status of translational research on PRS in commonneurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Institute for Genomic Medicine, University Medical Centre Ljubljana, Slovenia. mojca.cizek.sajko@kclj.si.
- National Institute for Health and Care Research (NIHR) HealthTech Research Centre (HRC) in Diagnostic and Technology Evaluation, Newcastle, United Kingdom; Translational and Clinical Research Institute, Faculty of Medic…
- Faculty of Science and Mathematics, University of Tuzla, Bosnia and Herzegovina.
- Clinical Institute for Genomic Medicine, University Medical Centre Ljubljana, Slovenia.
Zitieren
APA
Čižek Sajko, M., Suklan, J., Osmanović, D., & Peterlin, B. (2025). Translational Research on Polygenic Risk Scores in Common Neurodegenerative Diseases - A Scoping Review Protocol. Acta Medica Academica. https://doi.org/10.5644/ama2006-124.463
Vancouver
Čižek Sajko M, Suklan J, Osmanović D, Peterlin B. Translational Research on Polygenic Risk Scores in Common Neurodegenerative Diseases - A Scoping Review Protocol. Acta Medica Academica. 2025. doi:10.5644/ama2006-124.463
BibTeX
@article{iekSajko2025,
author = {Čižek Sajko, Mojca and Suklan, Jana and Osmanović, Džanan and Peterlin, Borut},
title = {Translational Research on Polygenic Risk Scores in Common Neurodegenerative Diseases - A Scoping Review Protocol},
journal = {Acta Medica Academica},
year = {2025},
doi = {10.5644/ama2006-124.463}
}
EUVIMED